Boule Diagnostics AB Stock Börse Stuttgart
Equities
8BD
SE0011231158
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.864 EUR | +5.37% | +3.85% | -7.99% |
05-08 | Boule Diagnostics AB Appoints Rikke Rytter as Director | CI |
05-07 | Transcript : Boule Diagnostics AB, Q1 2024 Earnings Call, May 07, 2024 |
Sales 2024 * | 579M 55.01M 50.7M 74.98M | Sales 2025 * | 609M 57.86M 53.33M 78.87M | Capitalization | 396M 37.64M 34.69M 51.3M |
---|---|---|---|---|---|
Net income 2024 * | 35M 3.33M 3.06M 4.53M | Net income 2025 * | 43M 4.09M 3.77M 5.57M | EV / Sales 2024 * | 0.77 x |
Net Debt 2024 * | 47.3M 4.49M 4.14M 6.13M | Net Debt 2025 * | 40.53M 3.85M 3.55M 5.25M | EV / Sales 2025 * | 0.72 x |
P/E ratio 2024 * |
11.2
x | P/E ratio 2025 * |
9.02
x | Employees | 200 |
Yield 2024 * |
2.3% | Yield 2025 * |
3.38% | Free-Float | 61.67% |
Latest transcript on Boule Diagnostics AB
1 day | +5.37% | ||
1 week | +3.85% | ||
1 month | +5.37% | ||
3 months | +6.01% | ||
6 months | +0.23% | ||
Current year | -7.99% |
Managers | Title | Age | Since |
---|---|---|---|
Holger Lembrér
DFI | Director of Finance/CFO | - | 12-31 |
Aishat Bislieva
HRO | Human Resources Officer | - | 22-09-30 |
Fredrik Ekdahl
PRN | Corporate Officer/Principal | - | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 20-12-31 | |
Chairman | 72 | 20-12-31 | |
Director/Board Member | 57 | 13-12-31 |
Date | Price | Change |
---|---|---|
24-05-31 | 0.864 | +5.37% |
24-05-30 | 0.82 | +0.49% |
24-05-29 | 0.816 | -2.63% |
24-05-28 | 0.838 | -.--% |
24-05-27 | 0.838 | +0.72% |
Delayed Quote Börse Stuttgart, May 31, 2024 at 09:27 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.61B |
- Stock Market
- Equities
- BOUL Stock
- 8BD Stock